AbbVie leads today's analyst activity. The pharma giant's average target price rose to $273.86. That marks a fresh consensus high across 23 Buy-rated analysts.
Amgen also drew upward revisions. Its average target climbed to $378.31. The biotech now holds 4 Buy ratings, 16 Holds, and 13 Sells — a mixed picture, but improving momentum.
The sharpest downgrade of the session hit Paramount Skydance. The media company's consensus target dropped to $9.81 from $10.12. Short interest sits at 9.7% of free float. That bearish positioning compounds the analyst pressure.
Fidelity National Information Services also saw target cuts. The fintech's average target fell to $51.09 from $52.45. Short interest at 4.1% of free float remains modest. But with 14 Sell ratings, analysts remain broadly cautious.
On the positive side, Motorola Solutions targets edged higher to $522.73. American Express targets rose to $375.50. Insurance broker targets climbed to $290.44.
The day's pattern is clear. Healthcare and financial services got upgrades. Media stocks drew cuts.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
